Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
andreas.damianou@ndm.ox.ac.uk

Research groups

Mass Spectrometry for Drug Target Discovery

Andreas Damianou

Postdoctoral Researcher

Recent publications

Integrative proximal-ubiquitomics profiling for deubiquitinase substrate discovery applied to USP30
Journal article

Damianou A. et al, (2025), Cell Chemical Biology
Deubiquitinases in muscle physiology and disorders.
Journal article

Olie CS. et al, (2024), Biochem Soc Trans, 52, 1085 - 1098
Proximity proteomics reveals UCH-L1 as an essential regulator of NLRP3-mediated IL-1β production in human macrophages and microglia.
Journal article

Liang Z. et al, (2024), Cell Rep, 43
Oncogenic mutations of KRAS modulate its turnover by the CUL3/LZTR1 E3 ligase complex.
Journal article

Damianou A. et al, (2024), Life Sci Alliance, 7
Proximity proteomics reveals UCH-L1 as an NLRP3 interactor that modulates IL-1β production in human macrophages and microglia
Preprint

Liang Z. et al, (2023)

More publications